Cqenc Pharma Private Limited
About Cqenc Pharma Private Limited
Data last updated:
Cqenc Pharma Private Limited is a private limited company based in Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 07 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC329247. Its GSTIN is 07AAHCC3966F1ZK (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Shubham Kumar Sharma and Ruchi Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 377 Saraswati Bhandar, Delhi, India – 110031.
As per the financials filed for FY 2024, the company reported a revenue of ₹90.89 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹5,971 (net margin 0.1%) and EBITDA of ₹7.96 Lakh (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cqenc Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address377 Saraswati Bhandar, Delhi, India – 110031
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Cqenc Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cqenc Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cqenc Pharma Private Limited, buy the company report.
Financials of Cqenc Pharma Private Limited
FY 2024 filings availableCqenc Pharma Private Limited reported revenue of ₹90.89 Lakh (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 13% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.96 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,971 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cqenc Pharma Private Limited, buy the company report.
Board of directors of Cqenc Pharma Private Limited
Cqenc Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Kumar Sharma Also directs: Ishqbaaz Intellectual Private Limited | Director | 07 Feb 2018 | 8 Years 8 Months | Current |
| Ruchi Agarwal | Additional Director | 16 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Cqenc Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stanqualis Healthcare Private Limited | ₹90.94 Lakh (FY 2025) | -19.0% | Delhi, India | |||
| Kristaa Clean Carbon Private Limited | ₹90.94 Lakh (FY 2025) | 78.0% | Coimbatore, Tamil Nadu, India | |||
| Altona Traders Private Limited | ₹90.93 Lakh (FY 2023) | 3914.0% | Kolkata, West Bengal, India | |||
| Shiv Shakti Vanijya Private Limited | ₹90.92 Lakh (FY 2025) | 22.0% | Raipur, Chhattisgarh, India | |||
| Pioneer Hub Enterprises Private Limited | ₹90.9 Lakh (FY 2025) | 9.0% | Ernakulam, Kerala, India | |||
| Cqenc Pharma Private Limitedthis company | ₹90.89 Lakh (FY 2024) | ₹5,971 | 0.1% | 13.0% | Delhi, India | |
| Shri Lakshmi Vasant Spinners Private Limited | ₹90.89 Lakh (FY 2024) | -74.0% | Secunderabad, Telangana, India | |||
| Proven Health Solutions Private Limited | ₹90.89 Lakh (FY 2024) | -44.0% | New Delhi, Delhi, India | |||
| Digital Holdings Private Limited | ₹90.88 Lakh (FY 2024) | -9.0% | Chennai, Tamil Nadu, India | |||
| Multiplier Projects Private Limited | ₹90.8 Lakh (FY 2025) | 106.0% | New Delhi, Delhi, India | |||
| Delta Infotel Private Limited | ₹90.8 Lakh (FY 2025) | 0.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Cqenc Pharma Private Limited, buy the company report.
Auditor
Cqenc Pharma Private Limited is audited by Deepak Bichhoria & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deepak Bichhoria & Associates | FY 2023 | 019777C |
Shareholding
The shareholding of Cqenc Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cqenc Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cqenc Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cqenc Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cqenc Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCC3966F1ZK | Delhi | Active | 17 Feb 2018 |
To see the full GST registrations and return filing status of Cqenc Pharma Private Limited, buy the company report.
Recent activity
Cqenc Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Bhupendra Singh ceased to be Director on 20 Feb 2024.
Frequently asked questions
Cqenc Pharma is an active private limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 07 February 2018 (8+ years old) and is registered under CIN U74999DL2018PTC329247.
Cqenc Pharma has 2 current directors:
- Shubham Kumar Sharma - Director
- Ruchi Agarwal - Additional Director
The latest financial statements of Cqenc Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Cqenc Pharma is 07AAHCC3966F1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Cqenc Pharma is U74999DL2018PTC329247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cqenc Pharma was incorporated on 07 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cqenc Pharma by revenue are Stanqualis Healthcare Private Limited, Kristaa Clean Carbon Private Limited, Altona Traders Private Limited, Shiv Shakti Vanijya Private Limited, Pioneer Hub Enterprises Private Limited and 5 more, all in the same principal business activity (retail trading).
Bhupendra Singh ceased to be Director on 20 Feb 2024. Ila Sharma ceased to be Director on 16 Jan 2024. Ruchi Agarwal was appointed as Additional Director on 16 Jan 2024. Cqenc Pharma has 5 board changes on record in total.
The registered office of Cqenc Pharma is at 377 Saraswati Bhandar, Delhi, India – 110031.
Cqenc Pharma operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of Cqenc Pharma is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.